Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Kazia Therapeutics Ltd changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 144.0K | 158.1K | +14.1K (+9.8%) |
| Value | $902.9K | $1.14M | +$236.9K (+26.2%) |
New holders (3)
Institutions that held Kazia Therapeutics Ltd at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rockefeller Capital Management L.P. | 10,700 | $77.1K | 0.00% |
| Citigroup Inc | 639 | $4.68K | 0.00% |
| Morgan Stanley | 200 | $1.44K | 0.00% |
Sold out (2)
Institutions that held Kazia Therapeutics Ltd at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| GAMMA Investing LLC | 265 | $1.66K |
| SBI Securities Co., Ltd. | 100 | $627 |